Cogstate Limited [ASX:CGS] share price and news 2022

Company Description

Cogstate Ltd (CGS) is involved in Creation, validation and commercialisation of digital brain health assessments and Design and provision of quality assurance services in clinical trials, focused on the administration, scoring and recording of conventional brain health assessments. Cogstate solutions are widely used in both academic and industry sponsored research. Cogstate technology had been deployed in more than: 1,800 academic research studies and 400 industry sponsored clinical trials.

Cogstate Limited belongs to Health Care sector and under industry of Health Care Technology. You can get more information about this company via their website: http://www.cogstate.com.

This a small cap company with market cap of 165 millions.

Compared to Market and Sector

The following table compares the company to Market and Sector based on Earning, Price/Earning ratio(P/E), Price/Book ratio (P/B) and PE growth.

Company PE is less than both sector and market. while Company PB is greater than both sector and market. On the other hand, Company Earning is greater than both sector and market.

Earnings PE PB PE growth
Company 3 0 7.04 0
Market 0.85 22.3 1.99 0.84
Sector 1.29 25.9 4.23 1.53

Dividend Growth Chart

The following chart shows you how cgs dividend grows in the recent years.

No data